# Risk Factors for Non-Space-Occupying Postoperative Hemorrhages Following Brain Tumor Resection Without the Influence of Anticoagulant or Antiplatelet Therapy: A Ten-Year Single-Center Retrospective Analysis

**Authors:** Anatoli Pinchuk, Nikolay Tonchev, Anna Schaufler, Claudia A. Dumitru, Belal Neyazi, Klaus-Peter Stein, I. Erol Sandalcioglu, Ali Rashidi

PMC · DOI: 10.3390/neurolint18020030 · Neurology International · 2026-02-09

## TL;DR

This study identifies risk factors for small postoperative brain bleeds after tumor surgery, finding that tumor size and patient age are key predictors.

## Contribution

The study identifies tumor size and patient age as independent risk factors for non-space-occupying postoperative hemorrhages in brain tumor surgery.

## Key findings

- Non-space-occupying postoperative hemorrhages occurred in 5.6% of patients.
- Tumor size and patient age were identified as significant independent risk factors.
- No new neurological deficits were observed in patients with these hemorrhages.

## Abstract

Background/Objectives: Postoperative intracerebral hematomas (POHs) are a common complication following brain tumor surgery and are typically associated with unfavorable outcomes. While extensive hemorrhages have been studied extensively, smaller, Non-Space-Occupying hemorrhages are frequently detected, yet their clinical relevance and associated risk factors remain insufficiently understood. This study aimed to identify predictive factors for the occurrence of Non-Space-Occupying postoperative cerebral hemorrhages in patients undergoing brain tumor resection. Methods: A total of 1481 patients without a history of anticoagulant or antiplatelet therapy underwent brain tumor surgery at our neurosurgical institute over a ten-year period. Non-Space-Occupying postoperative hemorrhages were diagnosed in 84 patients using cranial computed tomography (cCT) or magnetic resonance imaging (cMRI) performed after the tumor resection. Demographic data, pre-existing comorbidities, and tumor characteristics were collected and analyzed. Results: Non-Space-Occupying POHs occurred in 5.6% of patients. The most frequent tumor type associated with POHs was glioblastoma multiforme (N = 33; 39.3%), followed by metastatic lesions (N = 9; 10.7%) and benign primary intracranial neoplasms (N = 31; 38%). None of the affected patients exhibited new neurological deficits or signs of increased intracranial pressure. A multivariate analysis identified the tumor size as an independent risk factor for Non-Space-Occupying POHs (p = 0.002), with patient age emerging as the strongest predictor (p = 0.001). Conclusions: Non-Space-Occupying POHs after a brain tumor resection are significantly associated with the tumor size, an advanced patient age, and the presence of pre-existing liver disease. The recognition of these risk factors may facilitate targeted perioperative monitoring and guide postoperative management strategies.

## Linked entities

- **Diseases:** glioblastoma multiforme (MONDO:0018177), liver disease (MONDO:0005154)

## Full-text entities

- **Genes:** HBG2 (hemoglobin subunit gamma 2) [NCBI Gene 3048] {aka HBG-T1, TNCY}
- **Diseases:** intra- or suprasellar tumors (MESH:D020863), metastases (MESH:D009362), symptoms (MESH:D012816), death (MESH:D003643), hypertension (MESH:D006973), Meningioma (MESH:D008579), POHs (MESH:D002543), cardiovascular disease (MESH:D002318), coagulation abnormalities (MESH:D001778), postoperative bleeding complications (MESH:D011183), midline shift (MESH:D020178), CNS lymphoma (MESH:D008223), contusion (MESH:D003288), POH (MESH:D019106), Liver disorders (MESH:D017093), cardiac disease (MESH:D006331), glioblastoma (MESH:D005909), cognitive or functional deficits (MESH:D003072), neurological deterioration (MESH:D009422), Brain Tumor (MESH:D001932), chronic inflammation (MESH:D007249), hepatic dysfunction (MESH:D008107), injury to (MESH:D014947), hematoma (MESH:D006406), gliomas (MESH:D005910), platelet dysfunction (MESH:D001791), coronary heart disease (MESH:D003327), neurotoxic (MESH:D020258), renal insufficiency (MESH:D051437), benign (MESH:D009369), diabetes mellitus (MESH:D003920), intracranial hemorrhage (MESH:D020300), Hemorrhages (MESH:D006470), tumor vascular malformations (MESH:D054079), vascular fragility (MESH:D005600), neurological deficits (MESH:D009461)
- **Chemicals:** Antiplatelet (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12942971/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12942971/full.md

## References

30 references — full list in the complete paper: https://tomesphere.com/paper/PMC12942971/full.md

---
Source: https://tomesphere.com/paper/PMC12942971